SkinBioTherapeutics acquires Dermatonics Limited for £2.93 million
LONDON, UK: SkinBioTherapeutics plc (AIM: SBTX) has entered into an agreement to acquire the issued share capital of Dermatonics Limited, a specialist in innovative topical and dermatological products in the skincare/woundcare space. The initial consideration is £1.68 million plus £1.25…